Cornell Researchers Discover a New Mechanism of Cancer Chemotherapy Resistance

The Smolka Lab, led by Prof. Marcus Smolka, molecular biology and genetics, recently published a study shedding light on a novel pathway that explains how cancer cells can become resistant to chemotherapy and offering a promising mechanism to prevent chemo-resistance —the process by which cancer cells become tolerant to chemotherapeutic drugs.

Cornell Startup Embark Founded to Assess Various Dogs’ Genealogy

Embark, a canine DNA testing company founded in 2015 by brothers Ryan and Adam Bokyo in Cornell’s Incubator for Life Science Companies, is now taking strides in studies of the canine genome. With the swab of a dog’s cheek, Embark can provide information about the dog’s genetic risk factors and ancestry.